Teacher Retirement System of Texas Sells 3,636 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Teacher Retirement System of Texas lowered its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 43.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,677 shares of the medical instruments supplier's stock after selling 3,636 shares during the quarter. Teacher Retirement System of Texas' holdings in ICU Medical were worth $726,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ICUI. Charles Schwab Investment Management Inc. lifted its position in ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock valued at $54,868,000 after acquiring an additional 27,927 shares during the period. Citigroup Inc. lifted its holdings in shares of ICU Medical by 100.4% during the third quarter. Citigroup Inc. now owns 28,965 shares of the medical instruments supplier's stock valued at $5,278,000 after purchasing an additional 14,512 shares during the last quarter. Cerity Partners LLC boosted its position in shares of ICU Medical by 33.2% in the 3rd quarter. Cerity Partners LLC now owns 9,846 shares of the medical instruments supplier's stock worth $1,794,000 after purchasing an additional 2,454 shares in the last quarter. FMR LLC grew its stake in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after buying an additional 100,345 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in ICU Medical by 16.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,997 shares of the medical instruments supplier's stock valued at $1,275,000 after buying an additional 991 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms have commented on ICUI. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. Finally, StockNews.com cut shares of ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday, March 27th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $168.67.

ICU Medical Stock Performance

NASDAQ ICUI traded up $1.19 during trading hours on Thursday, hitting $141.57. The company's stock had a trading volume of 549,553 shares, compared to its average volume of 264,438. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The company's 50 day simple moving average is $152.29 and its two-hundred day simple moving average is $162.93. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market cap of $3.47 billion, a P/E ratio of -30.98 and a beta of 0.73.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.